IRCT20210812052156N1招募中3 期
Evaluation of the effect of Linagliptin on the outcome of COVID-19 in hospitalized patient with Diabetes
Gonabad University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Consent to participate in research
- •Patients admitted to the ward with definite diagnosis of COVID-19 with PCR
- •Disease severity of mild to moderate
排除标准
- •Lack of interest to cooperate in research
- •History of allergies to Linagliptin
- •Taking interactive drugs at simultaneous use with linagliptin, according to FDA definition
- •Adverse drug reactions occurrence
研究者
相似试验
招募中
2 期
Effect of Linagliptin and Empagliflozine on diabetesIRCT20221016056201N1Arak University of Medical Sciences55
进行中（未招募）
1 期
Study on the positive effects of treatment with linagliptin on the arteries of patients with diabetestype 2 diabetes mellitusMedDRA version: 17.1Level: LLTClassification code 10045252Term: Type II diabetes mellitus without mention of complicationSystem Organ Class: 100000004861EUCTR2012-005220-15-NLniversity Medical Center Groningen
已完成
3 期
Off taRget Effects of Linagliptin monothErapy on Arterial Stiffness in Early diabetesDiabetes Mellitus type 2Type 2 diabetes10018424NL-OMON40278niversitair Medisch Centrum Groningen45
进行中（未招募）
1 期
Effects of Linagliptin in Addition to Empagliflozin on Islet Cell Physiology and Metabolic Control in Patients with Type 2 Diabetes Mellitus on Stable Metformin TreatmentType 2 Diabetes MellitusEUCTR2014-004895-48-DEProfil Institut für Stoffwechselforschung GmbH
招募中
3 期
The effect of linagliptin on microalbuminuria in diabetes patientsIRCT20171030037093N11Esfahan University of Medical Sciences80